Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

11106	Companies
244341	Keywords
172428	Articles
131670	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

PRESS RELEASE

published on 01/30/2026 at 00:00, 8 months 2 days ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation
BRIEF

published on 01/23/2026 at 00:05, 8 months 9 days ago

LIR Life Sciences finalise le protocole d'étude pour l'évaluation des agents transdermiques

Administration Transdermique LIR Sciences De La Vie Macromolécules Thérapeutiques Modèle De Peau De Porc Thérapies Sans Aiguilles
BRIEF

published on 01/23/2026 at 00:05, 8 months 9 days ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies
PRESS RELEASE

published on 01/23/2026 at 00:00, 8 months 9 days ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
LIR Life Sciences Corp. announces study design for transdermal penetration of therapeutic macromolecules using ex vivo porcine skin. Focus on needle-free delivery strategies for larger therapeutics

Needle-free Delivery LIR Life Sciences Therapeutic Macromolecules Transdermal Penetration Ex Vivo Porcine Skin
BRIEF

published on 01/16/2026 at 00:05, 8 months 16 days ago

LIR Life Sciences lance une étude animale sur les thérapies transdermiques contre l'obésité

Administration Transdermique Thérapie De L'obésité Étude Animale LIR Sciences De La Vie Basé Sur Les BPL/BPI
BRIEF

published on 01/16/2026 at 00:05, 8 months 16 days ago

LIR Life Sciences Initiates Animal Study on Transdermal Obesity Therapies

Transdermal Delivery Obesity Therapy Animal Study LIR Life Sciences GLP/GIP-based
PRESS RELEASE

published on 01/16/2026 at 00:00, 8 months 16 days ago

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity

Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF

published on 01/09/2026 at 00:05, 8 months 23 days ago

LIR Life Sciences collabore avec Neuland Labs au développement de peptides

LIR Sciences De La Vie Laboratoires Neuland Peptides Pénétrant Dans Les Cellules Plateforme Transdermique Collaboration En R&D
BRIEF

published on 01/09/2026 at 00:05, 8 months 23 days ago

LIR Life Sciences Collaborates with Neuland Labs on Peptide Development

R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE

published on 01/09/2026 at 00:00, 8 months 23 days ago

LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration

Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation

Accesswire

Published on 10/01/2026 at 08:02, 52 minutes ago

Southern Energy Announces Results of Annual Meeting and Board Changes
Published on 10/01/2026 at 01:21, 7 hours 33 minutes ago

Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 7 hours 54 minutes ago

Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 9 hours 24 minutes ago

Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 12 hours 19 minutes ago

Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited

View all ACCESSWIRE

EQS Group

Published on 10/01/2026 at 08:35, 19 minutes ago

European consumers dissatisfied with rising costs in cross-border online shopping reveals Nielsen IQ study, commissioned by agency KleinS
Published on 10/01/2026 at 08:33, 21 minutes ago

Lenzing AG launches fully underwritten capital increase with subscription rights
Published on 10/01/2026 at 08:30, 24 minutes ago

Suspension- Schroders PLC
Published on 10/01/2026 at 08:30, 24 minutes ago

Suspension- Beazley PLC
Published on 10/01/2026 at 08:30, 24 minutes ago

Suspension: Notting Hill Genesis

Les Echos

Published on 10/01/2026 at 08:30, 24 minutes ago

Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 24 minutes ago

Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat
Published on 10/01/2026 at 08:30, 24 minutes ago

Eurazeo ouvre un bureau à Abu Dhabi et renforce son engagement au Moyen-Orient
Published on 10/01/2026 at 08:00, 54 minutes ago

CNP Assurances and Embracon complete their combination to create a leading consórcio player in Brazil
Published on 10/01/2026 at 08:00, 54 minutes ago

CNP Assurances et Embracon finalisent leur rapprochement pour former un acteur majeur du consórcio au Brésil

View all LES ECHOS COMFI WIRE